Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Clinical trial NCT02413138 · TERMINATED
Trial details
- NCT number
- NCT02413138
- Sponsor
- Versartis Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-08
- Primary completion
- 2017-11-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.